We are live on
!
Find out more
VFA
Values First Advisors Portfolio holdings
AUM
$192M
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.29%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
–
AUM
$139M
AUM Growth
-$1.6M
(-1.1%)
Cap. Flow
+$2.51M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
29.02%
Holding
165
New
8
Increased
106
Reduced
38
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GTM
ZoomInfo Technologies
GTM
|
+$516K |
| 2 |
DoubleVerify
DV
|
+$495K |
| 3 |
AAN
The Aaron's Company Inc
AAN
|
+$430K |
| 4 |
Emergent Biosolutions
EBS
|
+$390K |
| 5 |
MongoDB
MDB
|
+$356K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$1.01M |
| 2 |
Dynatrace
DT
|
+$887K |
| 3 |
NTUS
Natus Medical Inc
NTUS
|
+$418K |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$334K |
| 5 |
Ascendis Pharma A/S
ASND
|
+$313K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.9% |
| 2 | Healthcare | 14.62% |
| 3 | Industrials | 12.21% |
| 4 | Real Estate | 6.65% |
| 5 | Financials | 5.24% |
Similar funds
KWM
SCGDR
KC
CVSC
CA
WIA
AGA
LFIA
Values First Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Values First Advisors held 165 positions worth $139M, down 1.1% from $141M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Values First Advisors's Q3 2022 filing shows 8 new, 106 increased, 38 reduced and 9 closed positions. Its largest new stake was DoubleVerify: 19,213 shares worth $525K. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $1.01M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.
- Values First Advisors's largest Q3 2022 buy was DoubleVerify: 19,213 shares worth $525K.
- Values First Advisors added most to ZoomInfo Technologies in Q3 2022, an estimated $516K increase.
- Values First Advisors's biggest Q3 2022 reduction was Ascendis Pharma A/S, cutting an estimated $313K.
- Values First Advisors fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $1.01M.
- Values First Advisors's ten largest holdings make up 29% of its $139M portfolio in Q3 2022.
- Values First Advisors opened 8 new positions and closed 9 in Q3 2022.
- Values First Advisors's portfolio value fell 1.1% quarter-over-quarter to $139M.
Based on Values First Advisors's 13F filing for Q3 2022, filed 2 Dec 2022.